NO992008D0 - New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes - Google Patents

New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Info

Publication number
NO992008D0
NO992008D0 NO992008A NO992008A NO992008D0 NO 992008 D0 NO992008 D0 NO 992008D0 NO 992008 A NO992008 A NO 992008A NO 992008 A NO992008 A NO 992008A NO 992008 D0 NO992008 D0 NO 992008D0
Authority
NO
Norway
Prior art keywords
syndromes
estrogen
enantiomers
cis
prevention
Prior art date
Application number
NO992008A
Other languages
Norwegian (no)
Other versions
NO992008L (en
Inventor
Poul Jacobsen
Svend Treppendahl
Paul Stanley Bury
Anders Kanstrup
Lise Brown Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO992008D0 publication Critical patent/NO992008D0/en
Publication of NO992008L publication Critical patent/NO992008L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO992008A 1996-10-28 1999-04-27 New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes NO992008L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK120296 1996-10-28
PCT/DK1997/000482 WO1998018775A1 (en) 1996-10-28 1997-10-28 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Publications (2)

Publication Number Publication Date
NO992008D0 true NO992008D0 (en) 1999-04-27
NO992008L NO992008L (en) 1999-06-25

Family

ID=8102133

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992008A NO992008L (en) 1996-10-28 1999-04-27 New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Country Status (8)

Country Link
EP (1) EP0934298A1 (en)
JP (1) JP2001502707A (en)
AU (1) AU4771997A (en)
CA (1) CA2269970A1 (en)
IL (1) IL129624A0 (en)
NO (1) NO992008L (en)
WO (1) WO1998018775A1 (en)
ZA (1) ZA979644B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2207982T3 (en) * 1998-12-30 2004-06-01 Signal Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR THE MODULATION OF ESTROGEN RECEPTORS.
CO5251465A1 (en) 2000-01-26 2003-02-28 Pfizer Prod Inc COMPOSITIONS AND PROCEDURES TO TREAT OSTEOPOROSIS AND REDUCE CHOLESTEROL
ATE532777T1 (en) 2004-09-21 2011-11-15 Marshall Edwards Inc SUBSTITUTED CHROMEDER DERIVATIVES, MEDICATIONS AND APPLICATIONS IN THERAPY
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
US20100173983A1 (en) * 2007-03-16 2010-07-08 David Brown Method for inducing autophagy
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
PL3253208T3 (en) 2015-02-02 2021-11-08 Mei Pharma, Inc. Combination therapies for use in the treatment of breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (en) * 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
IL129624A0 (en) 2000-02-29
NO992008L (en) 1999-06-25
EP0934298A1 (en) 1999-08-11
AU4771997A (en) 1998-05-22
WO1998018775A1 (en) 1998-05-07
CA2269970A1 (en) 1998-05-07
ZA979644B (en) 1998-04-28
JP2001502707A (en) 2001-02-27

Similar Documents

Publication Publication Date Title
NO944857D0 (en) Fluorenyl-containing metallocenes, process for their preparation and process for polymerization of olefins using the metallocenes
DK0718239T3 (en) Sol-gel process for the preparation of pure or mixed zirconia, microspheres and coatings which can be used as
AU2675095A (en) Indol derivatives useful for the treatment of migraine, composition and utilization
DK0760238T3 (en) Preparation that can be administered percutaneously for the treatment of urinary disorders
NO20004151D0 (en) Iron dextran compound for use as a component in a therapeutic composition for profile ash or treatment of iron deficiency, a process for the preparation of the iron dextran compound and the use of the compound for the preparation of a parent compound
EE03242B1 (en) Method of continuous boiling of must, method of making beer from this must and beer produced by this method
NO970212D0 (en) Process for the preparation of the enantiomers of O-demethyltramadol
NO961604L (en) Keto group-introducing enzyme, DNA encoding the same, as well as process for producing ketocarotenoid
NO911956L (en) PROCEDURE FOR THE PREPARATION OF OXYDANT SENSITIVE AND INSENSITIVE, AROMATIC ESTERS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS
NO992010D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992008D0 (en) New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992009D0 (en) New trans-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO171484C (en) APPLICATION OF SUGARCARCOOL, POLYOXYLYCYLENETS OR ETHMONOSACCHARIDE OR MIXTURES THEREOF BASED FOR SOMATOSTATINES AND CALCITONINES FOR AA INCREASED BIOTAILABILITY OF THE PEPTIDES ORAL OR RECTAL.
NO992005D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992003D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
IT8468235A1 (en) New derivatives of 3-benzylidene-camphor, process for their preparation and their use as protective agents against UV rays and as drugs.
NO992002D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992004D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992007D0 (en) Novel (-) Enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992006D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
DK158990C (en) CHOLESTA STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATE FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES
NO983227L (en) Mixtures consisting essentially of polyethylene, as well as the process for free
NO985535D0 (en) Process for the preparation of 1,3-alkanediols
NO973486D0 (en) Substituted indanylidine acetylguanidines, process for their preparation, their use as medicaments or diagnostics and medicaments containing the compounds
NO865283D0 (en) MATERIALS WHICH CAN USE AS, PROTECTIVE SCREEN OR FOR DISPOSAL OF HEAT.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application